FT Vest U.S. Equity Deep Buffer ETF - October (DOCT)

The FT Vest U.S. Equity Deep Buffer ETF - October (ticker DOCT) is a structured equity fund that wraps a broad U.S. stock portfolio inside an options collar — a defined hedge that limits the investor’s loss to 15 percent over a 12-month period while capping gains at around 15 percent in exchange. It is designed for investors who want to own equities but find standard market volatility intolerable and are willing to trade away some upside to sleep at night.

What the buffer actually costs you

The appeal of DOCT is simple: you cannot lose more than 15 percent in a 12-month rolling period. If the market falls 30 percent, you only give back 15. But nothing in investing is free. The fund buys that protection by selling the top of any rally — no matter how strong the year, your gain caps at roughly 15 percent annualized. In a roaring bull market, a standard S&P 500 index fund will blow past DOCT. In a crash, DOCT shines.

The mechanism is an options collar: the fund sells upside call options and uses the premium to buy downside puts. This is the same hedge structure that sophisticated investors use when they want to lock in a profit on a large position, except here it wraps around the entire portfolio continuously. The annual reset (each October) means the buffer resets; losses or gains from the previous year do not carry forward.

This creates a specific trade-off in investor psychology. Winning years feel capped; losing years feel cushioned. Over time, the real question is whether the “sleep well” value of a 15 percent floor exceeds the opportunity cost of missing the occasional banner year. For most investors in a rising market, that math unfolds over decades.

Who issues it and how it’s structured

DOCT is issued by Flagstone Financial Inc., a subsidiary entity through Vest Finance, which specializes in structured notes and buffer strategies. The fund is not a simple ETF — it is a series of linked options contracts wrapped in a fund wrapper, which makes it legally a note rather than a fund in the traditional sense, though it trades and feels like an ETF.

That distinction matters for one reason: if Flagstone ever became insolvent, the note holders would be unsecured creditors. In practice, Flagstone’s backers have kept the entity well-capitalized, and no meaningful default risk has emerged, but it is not zero. A traditional ETF backed by a diversified fund sponsor (say, Vanguard or BlackRock) carries less counterparty risk simply because the sponsor is larger and more entrenched.

The annual reset mechanic is also important. On the anniversary of purchase (or the anniversary date in October each year), the buffer resets. A loss of 14 percent in year one does not carry forward to year two — year two starts fresh with a new 15 percent floor. This prevents what is sometimes called a “drawdown trap,” where a series of modest losses stack up over time. But it also means that if you buy DOCT on November 2 and the market crashes by year-end, you may only have a few weeks of buffer coverage before the reset date arrives.

The real risks

Opportunity cost is the most underrated risk. In a sustained bull market (the 1990s, 2010s, 2020–2021), a 15 percent annual cap cost investors dearly. A portfolio with DOCT would have trail a diversified basket of equities by hundreds of basis points cumulatively. That gap is not a flaw; it is the price of the hedge. But it must be consciously chosen, not stumbled into.

Liquidity and trading costs are secondary but real. DOCT is not as widely held as a plain S&P 500 index fund, so bid-ask spreads can widen during stress, exactly when the buffer is most valuable and the investor most tempted to sell. On calm days the spread is tight; on a crash day, liquidity can dry up.

Tax inefficiency can bite as well. The annual options rehedging — selling calls, buying puts — can generate taxable events. In a taxable account (not an IRA or 401k), this can create an unexpected tax bill in years when you think you have flat returns.

Single-digit buffer miscalculation trips up some buyers: a 15 percent cap sounds like plenty of protection until you remember that a garden-variety bear market (2000–2002, 2008–2009, 2020, 2022) often swallows 30–50 percent of equity value in months. DOCT limits your loss to 15 percent, but it does not spare you from watching the broader market crater. Psychologically, it helps; mathematically, it does not eliminate drawdown risk for a majority-equity portfolio.

How to research DOCT

Start with the fund’s prospectus and fact sheet (available on the issuer’s website and most brokers), which detail the exact buffer mechanics, the strike prices of the embedded options, and the expense ratio. The prospectus also lays out the credit risk of the note issuer — read it carefully if you are putting a large sum into DOCT.

Track how the buffer has performed relative to the S&P 500 over several calendar years, especially years that include both rallies and declines. The fund’s net asset value (NAV) and price should trade very close (they do not always; watch the premium or discount). Most importantly, ask yourself honestly: would I sell this position during the next crash, or would I hold it? If you would sell, the buffer’s value to you is low. If you would hold and use the capped loss as a reason to stay calm, the buffer may be worth its cost.

For context, the Cboe Volatility Index (VIX) peaks during the worst market stress — on those days, owning anything that caps your pain can feel invaluable, even if it cost you three years of slightly lower gains to get it.